In two other ovarian cancer cell lines, OAW42 and OVCAR3, both sensitive to cisplatin treatment, UCA1 expression levels were around 100‐ and 200‐fold lower respectively than in OAW42‐R (Fig. 1B). This evidence concerns the gene UCA1 and ovarian carcinoma.